Beigene Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beigene Ltd with three other
miscellaneous service companies in Asia:
BGI Genomics Co Ltd
sales of 2.80 billion Chinese Renmimbi [US$410.90 million]
of which 42%
was Basic research and clinical application ),
Takara Bio Inc
(35.84 billion Japanese Yen [US$340.13 million]
of which 88%
was Bio support), and
Chabiotech Co Ltd
based in KOREA (SOUTH)
(534.61 billion Korean Won [US$456.56 million]
of which 93%
was health care).
Beigene Ltd reported sales of HK$3.35 billion (US$432.84 million)
December of 2019.
increase of 115.9%
versus 2018, when the company's sales were HK$1.55 billion.